1 |
Laborda J. The role of the epidermal growth factor-like protein dlk in cell differentiation. Histol Histopathol 2000;15:119-29.
|
2 |
Favata MF, Horiuchi KY, Manos EJ, Daulerio, AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998;273:18623-32.
DOI
ScienceOn
|
3 |
Dang ZC, Lowik CW. Differential effects of PD98059 and U0l26 on osteogenesis and adipogenesis. J Cell Biochem 2004; 92:525-33.
DOI
ScienceOn
|
4 |
Fenaux P, Chevret S, Guerci A, Fegueux N, Dombret H, Thomas X, Sanz M, Link H, Maloisel F, Gardin C, Bordessoule D, Stoppa AM, Sadoun A, Muus P, Wandt H, Mineur P, Whittaker JA, Fey M, Daniel MT, Castaigne S, Degos L. Long-term followup confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. Leukemia 2000; 14:1371-7.
DOI
ScienceOn
|
5 |
Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux, N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 1999;94: 1192-200.
|
6 |
Yun Z, Lin Q, Giaccia AJ. Adaptive myogenesis under hypoxia. Mol Cell Biol 2005;25:3040-55.
DOI
ScienceOn
|
7 |
Miller VA, Benedetti FM, Rigas JR, Verret AL, Pfister DG, Straus D, Kris MG, Crisp M, Heyman R, Loewen GR, Truglia JA, Warrell RP, Jr. Initial clinical trial of a selective retinoid X receptor ligand, LGD1069. J Clin Oncol 1997;15:790-5.
|
8 |
Shalinsky DR, Bischoff ED, Gregory ML, Lamph WW, Heyman RA, Hayes JS. Thomazy V, Davies PJ. Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice. Clin Cancer Res 1996;2:511-20.
|
9 |
Laborda J. The role of the epidermal growth factor-like protein dlk in cell differentiation. Histol Histopathol 2000;15:119-29.
|
10 |
Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351:95-105.
DOI
ScienceOn
|
11 |
Ahn NG, Nahreini TS, Tolwinski NS, Resing KA. Pharmacologic inhibitors of MKK1 and MKK2. Methods Enzymol 2001;332: 417-31.
DOI
|
12 |
Katayama K, Wada K, Miyoshi H, Ohashi K, Tachibana M, Furuki R, Mizuguchi H, Hayakawa T, Nakajima A, Kadowaki T, Tsutsumi Y, Nakagawa S, Kamisaki Y, Mayumi T. RNA interfering approach for clarifying the PPARgamma pathway using lentiviral vector expressing short hairpin RNA. FEBS Lett 2004;560: 178-82.
DOI
ScienceOn
|
13 |
Kim Y, Lin Q, Zelterman D, Yun Z. Hypoxia-regulated delta-like 1 homologue enhances cancer cell sternness and tumorigenicity. Cancer Res 2009;69:9271-80.
DOI
ScienceOn
|
14 |
De los Santos M, Zambrano A, Aranda A. Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells. Mol Cancer Ther 2007;6:1425-32.
DOI
ScienceOn
|
15 |
Natale RB. Dual targeting of the vascular endothelial growth factor receptor and epidermal growth factor receptor pathways with vandetinib (ZD6474) in patients with advanced or metastatic non-small cell lung cancer. J Thorac Oncol 2008;3:S128-30.
DOI
ScienceOn
|
16 |
Yin D, Xie D, Sakajiri S, Miller CW, Zhu H, Popoviciu ML, Said JW, Black KL. Koeffler HP. DLKI: increased expression in gliomas and associated with oncogenic activities. Oncogene 2006;25: 1852-61.
DOI
ScienceOn
|
17 |
Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogenactivated protein kinase kinase in vitro and in vivo. J BioI Chem 1995;270:27489-94.
DOI
|
18 |
Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol 2006;66:606-30.
DOI
ScienceOn
|
19 |
Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995;80:225-36.
DOI
ScienceOn
|
20 |
Berwick DC, Calissano M, Comess JD, Cook SJ, Latchman DS. Regulation of Bm-3a N-terminal transcriptional activity by MEK1/2-ERK1/2 signalling in neural differentiation. Brain Res 2009;1256:8-18.
DOI
ScienceOn
|
21 |
Cuenda A, Alessi DR. Use of kinase inhibitors to dissect signaling pathways. Methods Mol Biol 2000;99:161-75.
|
22 |
Van Limpt VA, Chan AJ, Van Sluis PG, Caron HN, Van Noesel CJ, Versteeg R. High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type. Int J Cancer 2003;105:61-9.
DOI
ScienceOn
|
23 |
Sakajiri S, O'Kelly J, Yin D, Miller CW, Hofmann WK, Oshimi K, Shih L Y, Kim KH, Sul HS, Jensen CH, Teisner B, Kawamata N, Koeffier HP. Dlkl in normal and abnormal hematopoiesis. Leukemia 2005;19:1404-10.
DOI
ScienceOn
|
24 |
Smas CM, Sui HS. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 1993;73:725-34.
DOI
ScienceOn
|
25 |
von Lintig J, Vogt K. Filling the gap in vitamin A research. Molecular identification of an enzyme cleaving beta-carotene to retinal. J Biol Chem 2000;275:11915-20.
DOI
ScienceOn
|
26 |
Laborda J, Sausville EA, Hoffman T, Notario V. dlk, a putative mammalian homeotic gene differentially expressed in small cell lung carcinoma and neuroendocrine tumor cell line. J Biol Chem 1993;268:3817-20.
|
27 |
Bauer SR, Ruiz-Hidalgo MJ, Rudikoff EK, Goldstein J, Laborda J. Modulated expression of the epidermal growth factor-like homeotic protein dlk influences stromal-cell-pre-B-cell interactions, stromal cell adipogenesis, and pre-B-cell interleukin-7 requirements. Mol Cell Biol 1998;18:5247-55.
|
28 |
Kaneta M, Osawa M, Sudo K, Nakauchi H, Farr AG, Takahama Y. A role for pref-1 and HES-1 in thymocyte development. J Immunol 2000; 164:256-64.
|
29 |
Smith MA, Anderson B. Where to next with retinoids for cancer therapy? Clin Cancer Res 2001;7:2955-7.
|
30 |
Goodman DS, Huang HS. Biosynthesis of vitamin a with rat intestinal enzymes. Science 1965;149:879-80.
DOI
ScienceOn
|
31 |
Floridon C, Jensen CH, Thorsen P, Nielsen O, Sunde L, Westergaard JG, Thomsen SG, Teisner B. Does fetal antigen 1(FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation. Differentiation 2000;66:49-59.
DOI
ScienceOn
|
32 |
Pearson AD, Pinkerton CR, Lewis IJ, Imeson J, Ellershaw C, Machin D; European Neuroblastoma Study Group; Children's Cancer and Leukaemia Group (CCLG formerly United Kingdom Children's Cancer Study Group). High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial. Lancet Oncol 2008;9: 247-56.
DOI
ScienceOn
|
33 |
Li L, Forman SJ, Bhatia R. Expression of DLK1 in hematopoietic cells results in inhibition of differentiation and proliferation. Oncogene 2005;24:4472-6.
DOI
ScienceOn
|
34 |
Villena JA, Kim KH, Sul HS. Pref-1 and ADSF/resistin: two secreted factors inhibiting adipose tissue development. Horm Metab Res 2002;34:664-70.
DOI
ScienceOn
|
35 |
Vasudevan SA, Nuchtem JG, Shohet JM. Gene profiling of high risk neuroblastoma. World J Surg 2005;29:317-24.
DOI
ScienceOn
|
36 |
Matthay KK, Haas-Kogan D, Constine LS. Neuroblastoma. In: Halperin, EC, Constine LS, Tarbell NJ, Kun LE, editors. Pediatric Radiation Oncology. Philadelphia: Lippincott Williams & Wilkins; 2005. p.179-222.
|
37 |
Tomehave D, Jensen CH, Teisner B, Larsson LI. FAI immunoreactivity in endocrine tumours and during development of the human fetal pancreas; negative correlation with glucagon expression. Histochem Cell Biol 1996;106:535-42.
DOI
ScienceOn
|
38 |
De Preter K, Vandesompele J, Heimann P, Beckman S, Schramm A, Eggert A, Stallings RL, Benoit Y, Renard M, De Paepe A, Laureys G, Piahlman S, Speleman F. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol 2006;7:R84.
DOI
|
39 |
Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003;3:203-16.
DOI
ScienceOn
|
40 |
Kushner BH. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med 2004;45: 1172-88.
|
41 |
Maris JM, Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol 1999;17:2264-79.
|